Results 221 to 230 of about 167,619 (306)

Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma [PDF]

, 1997
Y. Morita, Yoshitake Hayashi, Y Wang, T Kanamaru, Satoshi Suzuki, Kentaro Kawasaki, Kyosuke Ohta, Masahiro Yamamoto, Y Saitoh, Hiroshi Itoh, W F Doe   +10 more
openalex   +1 more source

The Light Chain Allosterically Enhances the Protease Activity of Murine Urokinase-Type Plasminogen Activator. [PDF]

Biochemistry
Torres-Paris C, Song HJ, Engelberger F, Ramírez-Sarmiento CA, Komives EA.   +4 more
europepmc   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor Levels as a Predictor of Kidney Replacement Therapy in Septic Patients with Acute Kidney Injury: An Observational Study. [PDF]

J Clin Med, 2022
Skalec T, Adamik B, Kobylinska K, Gozdzik W.   +3 more
europepmc   +1 more source

Role of LFB3 in Cell-specific cAMP Induction of the Urokinase-type Plasminogen Activator Gene [PDF]

, 1995
René Marksitzer, Aribert Stief, Pierre-Alain Menoud, Yoshikuni Nagamine   +3 more
openalex   +1 more source

Novel Biomarkers: Soluble Urokinase-Type Plasminogen Activator Receptor and Procalcitonin- and Histological Chorioamnionitis after Preterm Premature Rupture of Membranes. [PDF]

Reprod Sci
Jalkanen K, Virtanen A, Aittoniemi J, Flinck H, Ampuja S, Huhtala H, Tihtonen K.   +6 more
europepmc   +1 more source

A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells. [PDF]

Toxicol Res, 2022
Kim M, Moon A.
europepmc   +1 more source

Prognostic impact of stromal cell‐derived urokinase–type plasminogen activator in gastric carcinoma [PDF]

, 1999
Yasushi Okusa, Takashi Ichikura, Hidetaka Mochizuki   +2 more
openalex   +1 more source

Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA. [PDF]

Int J Mol Sci, 2022
Dreymann N, Wuensche J, Sabrowski W, Moeller A, Czepluch D, Vu Van D, Fuessel S, Menger MM.   +7 more
europepmc   +1 more source

The urokinase-type plasminogen activator system in cancer metastasis: A review [PDF]

, 1997
Peter A. Andreasen, Lars Kjøller, Lise Christensen, Michael J. Duffy   +3 more
openalex   +1 more source

Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes. [PDF]

Vasc Med, 2021
Höbaus C, Ursli M, Yussef SM, Wrba T, Koppensteiner R, Schernthaner GH.   +5 more
europepmc   +1 more source